Meetings/Workshops on Oncology in the United States (USA)

Submit a meeting

Select a location:
Australia (1) - France (1) - Germany (10) - India (1) - Italy (1) - Mexico (3) - Netherlands (5) - South Africa (1) - Switzerland (2) - United Arab Emirates (1) - United Kingdom (13) - United States (24) - ALL COUNTRIES (63)

1
Biomarkers Congress 2017 — Annual World Congress on Biomarkers & Clinical Research
27 Nov 2017 - 28 Nov 2017 • Atlanta, United States
Abstract:
PULSUS brings in a new spin on conferences by presenting the latest scientific improvements in Biomarkers and its clinical researches. Listen to motivating keynotes from thought leaders, pioneers across the globe. Atlanta is all set for an amazing event as PULSUS proudly presents the “Annual World Congress on Biomarkers & Clinical Research” on November 27-28, 2017. PULSUS cordially welcome researchers, academicians, students and business professionals in the field of BIOMARKERS from around the world to participate in the upcoming BIOMARKERS CONGRESS 2017. The meeting for this year will revolve around the theme “Explore the latest Biomarkers development in health and clinical research” thus relaying the most cutting edge findings in the field of Biomarkers Research.
Contact:
Safina Robinson;     Phone: [+1-800-982-0387];     Email: biomarkers@cmesocietyconferences.org
Topics:
Biomarker Conference, Biomarkers Conference 2017, Biomarkers Conferences, Biomarkers Congress, Biomarker Conferences USA, Biomarker Conferences, Biomarkers Congress 2017, Biomarker Conferences 2017, Biomarkers Society Conferences, Biomarkers cme conference
Event listing ID:
884468
Related subject(s):
2
Oncology Summit 2017 — International Oncology Summit
27 Nov 2017 - 28 Nov 2017 • Atlanta, United States
Abstract:
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summit’ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. International Oncology Summit will have an anticipated participation of 120+ delegates across the world to discuss the conference goal
Contact:
Rayan Wayne;     Phone: [8008582189];     Email: oncologyevents@alliedconferences.org
Topics:
Cancer Conferences USA, Cancer Meetings 2017, Oncology Conferences USA, Oncology Symposiums 2017, Oncology Conferences Atlanta.
Event listing ID:
902477
Related subject(s):
3
WCC-2017 — World Cancer Conference
29 Nov 2017 - 30 Nov 2017 • Florida, United States
Contact:
Carol Smith;     Phone: [8005204889];     Email: carolsmith.oap@gmail.com
Topics:
Breast Cancer  Colorectal Cancer Lymphoma  Lung Cancer  Blood Cancer Gynecologic cancer  Cancer Treatment and Prevention Herbal Treatments for Cancer Stem Cell Transplants Cancer Diagnosis Cancer Biomarkers Metastatic Cancer  Cancer Genomics Skin cancer
Event listing ID:
898627
4
Miami Brain Symposium, Inaugural
01 Dec 2017 • Coral Gables, United States
Abstract:
Continuing medical education focused on the latest advances in neuro oncology. Dynamic faculty! Excellent and timely topics from experts in neuro oncology.
Contact:
Julie Zimmett;     Phone: [786-596-2398];     Email: juliez@baptisthealth.net
Topics:
Brain cancer; neuro oncology
Event listing ID:
941497
Related subject(s):
5
Miami Neuro Symposium, Sixth Annual
02 Dec 2017 • Coral Gables, United States
Abstract:
Attendees will hear about the latest advances in neuro oncology, stroke treatment and neurocritical care from experts in the field.
Contact:
Julie Zimmett;     Phone: [786-596-2398];     Email: juliez@baptisthealth.net
Topics:
Stroke treatment; Neurocritical care; Neuro Oncology; CME
Event listing ID:
941463
Related subject(s):
6
Keystone Symposia: T Cell Dysfunction, Cancer and Infection
16 Jan 2018 - 20 Jan 2018 • Breckenridge, United States
Abstract:
T cell exhaustion is an acquired state of T cell dysfunction, associated with reduced T cell function, sustained expression of inhibitory receptors and a transcriptional state that is distinct from memory and effector T cells. T cell exhaustion is now recognized as a defining feature not only of chronic infections such as HIV, malaria and tuberculosis, but also of cancer. As a result, the search for effective approaches to reverse T cell exhaustion is the focus of immense therapeutic development. However, the similarities and differences between T cell dysfunction arising in chronic infection and tumors are not fully understood. Moreover, opportunities to identify new therapeutic approaches to reverse dysfunction based on parallels between the two disease states remain to be explored. This meeting will focus on the comparative biology and clinical therapeutics of T cell dysfunction in chronic viral infection and cancer. Drawing on leaders in fundamental T cell biology, computational science and clinical investigation, it will focus on common features and distinctive aspects of T cell dysfunction in cancer and chronic infection. The meeting will have broad relevance for T cell biology, tumor immunity, infectious disease and therapeutic development.
Contact:
Attendee Services; 970.262.1230; email: info@keystonesymposia.org
Event listing ID:
920896
Related subject(s):
7
Keystone Symposia: Tumor Metabolism
21 Jan 2018 - 25 Jan 2018 • Snowbird, Utah, United States
Abstract:
This conference brings together experts in the tumor metabolism field to discuss new concepts in the regulation and role of cancer metabolism in tumor growth, as well as strategies for targeting tumor metabolism for therapeutic benefit. This symposium is the premier conference for learning about the most important unpublished data in the tumor metabolism field and is invaluable to enhance accelerated discovery and development of new therapeutic approaches to target cancer metabolism.
Contact:
Attendee Services;     Phone: [970.262.2677 or 800.253.0685];     Email: info@keystonesymposia.org
Topics:
cancer research, basic mechanism, mitochondria, epigenetics
Event listing ID:
926020
Related subject(s):
8
Pathology Update 2018: What you need to know about new AJCC staging and WHO classifications
25 Jan 2018 - 27 Jan 2018 • Phoenix, United States
Abstract:
Dr. Mahul Amin, editor of the 8th edition of the AJCC Cancer Staging Manual, joins an elite roster of speakers for this third annual 2.5-day general surgical pathology course.  Covering a broad range of subjects in diagnostic pathology, the central themes for this year's course include staging changes found in the 8th edition of the AJCC tumor staging manual, and updates in WHO classification.  Organ systems discussed include breast, head and neck, gastrointestinal, pulmonary, soft tissue, gynecologic, genitourinary, endocrine, and hematologic.  Presentations will summarize changes to terminology and staging; these lectures also include practical discussion of diagnostic challenges, need-to-know molecular updates, and emerging issues.  Attendee participation is encouraged via audience response system and engaging case reviews.
Event listing ID:
942047
9
PRIMO — Practical Recommendations in Immuno and Molecular Oncology (PRIMO) Meeting
31 Jan 2018 - 03 Feb 2018 • Maui, United States
Abstract:
The PRIMO Meeting is an annual 3-day single-track conference focusing on the practical applications of emerging immuno and molecular oncology. Each day’s agenda is dedicated to specific tumor types, with the top experts sharing the latest data and applying them to real world cases.
Contact:
Jennifer Mahon;     Phone: [1-855-6-PRIMO-8 (1-855-677-4668)];     Email: support@primomeeting.org
Topics:
oncology, immunology, continuing medical education
Event listing ID:
907419
10
Updates in Cardio-Oncology 2018: Challenges and New Frontiers
01 Feb 2018 - 03 Feb 2018 • Scottsdale, United States
Abstract:
This course reviews clinically important information regarding the management of cardiac and vascular diseases affecting patients with cancer and cancer survivors. The interactive, practice-based format includes case presentations and state-of-the-art lectures in recent and topical developments in this emerging field. The goal is to improve quality, safety and outcomes for patients within the dynamic and interactive educational experience. The current state of knowledge of common cardiovascular complications such as heart failure (HF), myocardial ischemia, hypertension (HTN), thromboembolism, QT prolongation, and bradycardia is associated with frequently used anticancer medications.  An optional hands-on echocardiography workshop will be available.  Pre-registration is required.
Event listing ID:
957093
Related subject(s):
11
Keystone Symposia - Cancer Epigenetics: New Mechanisms, New Therapies
10 Feb 2018 - 14 Feb 2018 • Breckenridge, Colorado, United States
Abstract:
The field of epigenetics has recently emerged as an essential component of oncology research, with altered epigenetic modifications considered to be critical hallmarks of cancers. Unlike mutations, epigenetic aberrations are reversible and as a result, epigenetic therapies hold great promise as anti-cancer agents. For these novel therapies to succeed, a key challenge is to fully understand the nature and the mechanisms that lead to epigenetic changes in cancer. Another essential challenge is to make sense of the avalanche of data flowing from increasingly powerful "omics-based" technologies. Despite these challenges, never has the potential for scientific and clinical breakthroughs in this field been greater. Bringing together both the academic and the pharmaceutical communities, this Keystone Symposia conference will focus on: 1) The newest findings concerning the mechanisms by which epigenetic pathways are established and maintained in normal and stem cells, and how these go awry during aging and cancer, with a special emphasis on histone modifications, chromatin remodeling and the unexpected increased number of DNA modifications ((hydroxy)methylcytosine and methyladenine); 2) The growing roles of noncoding RNAs in cancer and the emergence of the new and exciting realm of RNA epigenetics; 3) Use of new omics technologies to interrogate altered epigenetic landscapes in tumors and assess their clinical implications; and 4) Novel and promising therapeutic drugs aimed at reversing specific epigenetic alterations. Ultimately, the meeting will provide great opportunities for senior and junior scientists to meet the leaders in the field from both academia and industry, hence forging exciting interdisciplinary interactions and creating potential new collaborations in the booming area of cancer epigenetics.
Contact:
Attendee Services;     Phone: [970.262.1230];     Email: info@keystonesymposia.org
Topics:
Cancer, genetics, genomics, drug discovery, epigenetics
Event listing ID:
948466
12
Keystone Symposia - Phosphoinositide Biology: New Therapeutic Targets Beyond Class I PI3K
11 Feb 2018 - 15 Feb 2018 • Taos, New Mexico, United States
Abstract:
Phosphoinositides have been recognized since the 1980s as important regulatory lipids supporting signal transduction from G protein-coupled receptors and receptor tyrosine kinases. The discovery of PI 3-kinases and their roles in carcinogenesis and immune regulation has created a fertile ground for translational expansion of the phosphoinositide field with a focus on cancer and inflammation. Most of these advances focused on Class I PI3Ks and PIP3-mediated signaling. However, research on other PI kinases and phosphoinositides has expanded substantially over the years. Class II and -III PI 3-kinases and less characterized 3-phosphorylated phosphoinositides are now rapidly emerging as key controllers of development, trafficking, nutrition-sensing and autophagy. Furthermore, phosphoinositides different from the 3-phosphorylated species are gaining momentum in many aspects of cell physiology and pathology. Exciting new developments include PI 4-kinases controlling vesicular trafficking and non-vesicular lipid transfer between membrane contacts, and new details are emerging on the role of inositol lipid phosphatases in trafficking, endocytosis and ciliary function. The recently recognized roles of PI 4-kinases as obligate host factors for certain RNA viruses, and their importance in parasitic organisms such as Plasmodium falciparum or Legionella pneumophila, have raised significant interest from pharmaceutical companies that now focus on inositol lipids other than the products of PI 3-kinases. By expanding our knowledge of phosphoinositides beyond class I PI3K products, this Keystone Symposia meeting represents a unique opportunity to bolster the rising interest in these under-explored avenues with a strong potential for translational impact.
Contact:
Attendee Services;     Phone: [970.262.1230];     Email: info@keystonesymposia.org
Topics:
development, drug discovery, cancer, infectious disease, cell signaling, genetics, cell physiology
Event listing ID:
948497
13
Keystone Symposia - Emerging Cellular Therapies: T Cells and Beyond
11 Feb 2018 - 15 Feb 2018 • Keystone, Colorado, United States
Abstract:
A new community of researchers is emerging that focuses on studying and developing cellular therapies against cancer and chronic infections. The field is advancing rapidly due to our deepening understanding of cell biology. New technologies permit efficient cell culture, gene transfer and genetic editing, enabling autologous and allogeneic cell therapy. With rapid development of CAR T cells, breakthrough FDA approval status, and fast-tracking clinical trials, competition is fierce in the biotechnology and pharmaceutical industries. Cell therapies with stem cells and T cells are in advanced clinical development that will enable widespread use for cancer and chronic infections such as HIV. Infusions of regulatory T cells (Tregs) have the potential to benefit patients with autoimmunity and transplantation. A goal of this conference is to bring together basic and translational scientists from these fields to identify current opportunities and challenges in cell therapies. Another goal is to bridge the fields of effector T cell and Treg cell therapies. The interdisciplinary features of this meeting should facilitate new collaborations and interactions between investigators who would not normally meet. This meeting is paired with the Keystone Symposia conference on "Lymphocytes and their Roles in Cancer."
Contact:
Attendee Services;     Phone: [970.262.1230];     Email: info@keystonesymposia.org
Topics:
T cell and B cell biology, cancer, genetics, genomics, drug discovery, infectious disease, HIV, translational medicine, stem cells
Event listing ID:
948485
14
Keystone Symposia: Lymphocytes and their Roles in Cancer
11 Feb 2018 - 15 Feb 2018 • Keystone, Colorado, United States
Abstract:
Leverage of the body’s own immune system is revolutionizing the way that we treat cancer as it can lead to dramatic and durable responses. Such anti-tumor therapies include reactivation of anti-tumor T cells, expansion of tumor-infiltrating lymphocytes (TILs), Chimeric antigen receptor (CAR) T cells and a variety of cancer vaccines. The focus or target of most these approaches are cells of the lymphocytic lineage (T, B, NK, dendritic cells), key components of both adaptive and innate immune response. At the same time, lymphocytes can also be malignant, as in the case of a large number of lymphocytic leukemia and lymphoma subtypes, and active components of the immune microenvironment, controlling tumor growth and anti-tumor response. This conference for the first time brings together scientists from these different areas of lymphocyte biology and provides an overview of lymphocyte development, transformation, terminal differentiation, location within the tumor microenvironment and anti-tumor activity. The conference also provides an update on novel therapy protocols that attempt to harness the function of lymphocytes against cancer and state-of-the-art technologies, including imaging and DNA/RNA sequencing approaches, that will help us visualize and molecularly dissect anti-tumor responses in experimental systems and cancer patients.
Contact:
Attendee Services;     Phone: [970.262.1230];     Email: info@keystonesymposia.org
Topics:
cancer, immunology, drug discovery, technologies, T cell biology, genetics, genomics
Event listing ID:
948548
15
Clinical and Multidisciplinary Hematology & Oncology: The 15th Annual Review
16 Feb 2018 - 18 Feb 2018 • Scottsdale, United States
Abstract:
This course will include a comprehensive update and management strategies of issues in hematologic and oncologic malignancies presenting new disease classification, treatment, and challenging cases. Course topics will focus on key hematologic diseases (dysproteinemias, acute and chronic leukemias, lymphomas), key solid tumors (breast, thoracic, GI, GU), and overlap topics of supportive, ancillary and diagnostic care. The course offers challenging and interactive sessions on pertinent issues involved with the care of patients.
Event listing ID:
920932
Related subject(s):
16
28th Annual Interdisciplinary Breast Center Conference
09 Mar 2018 - 14 Mar 2018 • Las Vegas, United States
Abstract:
The 28th Annual Interdisciplinary Breast Center Conference has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through a joint sponsorship of the University of Tennessee College of Medicine, an educational institution accredited by the ACCME to provide continuing medical education for physicians, and the National Consortium of Breast Centers, an international member-based organization of medical and industry professionals.
Contact:
Kimberly Bolin;     Phone: [(574)401-8115];     Email: kimberly@breastcare.org
Topics:
RT/Imaging, Breast Surgical Oncology, Breast Radiation Oncology
Event listing ID:
937454
Event website:
17
IHR — 15th Annual Indy Hematology Review
10 Mar 2018 • Indianapolis, United States
Abstract:
Indy Hematology Review is an educational event intended to facilitate the communication of new scientific knowledge and advance the practice of hematology. The preservation of the scientific integrity and educational value of this program is of paramount importance to Indy Hematology Education, Inc.
Contact:
Mwila Mejia;     Phone: [317-713-1531];     Email: mwila@conventionmanagers.com
Topics:
Multiple Myeloma: Emerging therapies, Waldenström's Macroglobulinemia: Emerging options and current treatment paradigms Complementopathies and Aplastic Anemia, Benign Hematology: Coagulopathies and beyond, Indolent Lymphomas and Hodgkin’s Lymphoma:, CHRONIC LYMPHOCYTIC LEUKEMIA: Targets, treatments and resistance, Aggressive B and T Cell Lymphomas: Treatment Paradigms in 2018, Chronic Myeloid Leukemia, Myeloproliferative disorders: What about JAK? PV, ET, MF, Beyond JAK 2: Mastocytosis, CMML, Eosinophilic and Neutrophilic leukemia; Treatments Paradigms and Diagnosis, Hematopoietic Stem Cell Transplantation: How I treat and when I transplant in 2018, Lymphoma, Benign Hematology and Coagulopathy, Recognition and Management of Toxicities of Oral Therapeutics in Hematologic Malignancies, Myeloproliferative disorders
Event listing ID:
968480
Related subject(s):
18
Gordon Research Seminar — DNA Damage, Mutation and Cancer
24 Mar 2018 - 25 Mar 2018 • Ventura, CA, United States
Abstract:
The Gordon Research Seminar on DNA Damage, Mutation and Cancer is a unique forum for graduate students, post-docs, and other scientists with comparable levels of experience and education to present and exchange new data and cutting edge ideas.
Event listing ID:
953749
Related subject(s):
19
Gordon Research Conference — DNA Damage, Mutation and Cancer
25 Mar 2018 - 30 Mar 2018 • Ventura, CA, United States
Abstract:
The 2018 Gordon Research Conference on DNA Damage, Mutation and Cancer is developed around the theme of exploiting fundamental knowledge to advance treatment and prevention. Rich and ever-increasing information is available on the specific mutations that are the molecular basis of cancer. Many mutations can be traced to specific types of damage to the DNA, while others arise from DNA replication errors or unknown causes. Technologies are being refined to determine the origins of these mutations, and monitor the accuracy and reproducibility of cancer genomic data. Biological and structural analyses can assess which mutations are functionally relevant. Specific mutations can confer vulnerabilities, making individual cancers more responsive to treatment with DNA damaging agents.
Event listing ID:
953651
Related subject(s):
20
Cancer Imaging and Therapy
02 Apr 2018 - 06 Apr 2018 • Hollywood, United States
Abstract:
The Cancer Imaging and Therapy conference will focus on optical methods in cancer, centered on imaging and treatment of cancer. The conference will accept submissions on topics on the molecular and cellular level, such as reporters and theranostics; on the tissue and pre-clinical (animal) level, such as pathology methods and advances in imaging of tumor models; and on human tissue and living human subjects, when specifically dealing with cancer. More generic biomedical optics and biophotonics research involving human tissues or living human subjects should be submitted to the Clinical and Translational Biophotonics conference at this congress.
Event listing ID:
836406
21
Acute Leukemia Forum 2018
12 Apr 2018 - 13 Apr 2018 • Newport Beach, United States
Abstract:
Since new discoveries and breakthroughs are critical to advance the treatment and management of acute leukemia, there is an urgent need to communicate the latest developments in the basic biology, induction and post-remission therapy, bone marrow transplant, and supportive care perspectives of ALL, AML, and MDS to physicians. The Acute Leukemia Forum (ALF) is a unique platform that enables worldwide prominent experts to share and discuss the latest research impacting treatment and management of these patients. ALF will focus on addressing the identified educational needs of healthcare professionals involved in caring for patients with acute leukemia and myelodysplasia.
Event listing ID:
956220
Related subject(s):
22
GEST 2018 — Global Embolization Symposium Technologies
17 May 2018 - 20 May 2018 • Miami Beach, FL, United States
Abstract:
Global Embolization Symposium and Technologies (GEST) serves as the definitive international embolotherapy resource, providing both clinically relevant research updates from the field and highly practical instruction. GEST 2018 U.S. will feature interactive education in the form of lectures, workshops, case presentations, oral abstract presentations and Q & A sessions. Exhibits showcasing the latest technology and services in support of the field also play a role in the important exchange of information. GEST 2018 will take place at the Lowes Miami Beach, an exquisite oceanfront backdrop within vibrant South Beach offering, in addition to learning, terrain to explore day and night.
Contact:
Phone: [305-279-2263];     Email: questions@ccmcme.com
Event listing ID:
927190
23
Gordon Research Seminar — Liquid Biopsy for Cancer
04 Aug 2018 - 05 Aug 2018 • Mount Holyoke College, South Hadley, MA, United States
Topics:
Advancements and Discoveries in Biological Fluid Interrogation for Detecting and Monitoring Cancer
Event listing ID:
960783
24
Gordon Research Conference — Liquid Biopsy for Cancer
05 Aug 2018 - 10 Aug 2018 • Mount Holyoke College, South Hadley, MA, United States
Topics:
Circulating Tumor Cells, ctDNA, and Extracellular Vesicles
Event listing ID:
960773

View all listed conferences in the United States (USA).



Conference-Service.com offers, as part of its business activities, a directory of upcoming scientific and technical meetings. The calendar is published for the convenience of conference participants and we strive to support conference organisers who need to publish their upcoming events. Although great care is being taken to ensure the correctness of all entries, we cannot accept any liability that may arise from the presence, absence or incorrectness of any particular information on this website. Always check with the meeting organiser before making arrangements to participate in an event!

Last updated: 11 November 2017